01/08/2026
Showing progress is promise!
https://youtu.be/n30JB7b5i8o?si=cLzBAnOuWxW3XGFj
Jeff Lichon
Dr. Adam Rogers, CEO of NervGen and a board-certified MD from Emory, joined "ChicagoLIVE" to discuss NVG-291, an experimental drug showing remarkable results...